Tags:

Alex Barlow


PRACTICE EMPHASIS:

Mr. Barlow’s main practice involves representing individual and institutional plaintiffs in complex litigation – particularly in cases involving a significant amount of scientific or medical evidence.

BIO:

Mr. Barlow has tried and won cases on behalf of a diverse spectrum of plaintiffs. Most recently he has represented mesothelioma victims, former college athletes suffering from neurodegenerative diseases as a result of their playing football, victims of defective medical devices and municipalities ravaged by the opioid epidemic. During his career Mr. Barlow has won verdicts on behalf of his clients in the areas of toxic tort, catastrophic injury, and commercial litigation.

Mr. Barlow was the lead lawyer in achieving settlements totaling over $80 million in the transvaginal mesh litigation. In past pharmaceutical litigation, he represented and achieved a confidential settlement on behalf of over 700 male children who developed gynecomastia as a result of taking Janssen Pharmaceuticals’ antipsychotic drug, Risperdal. He also achieved a judgment against GlaxoSmithKline over the mis-marketing and side effects of its blockbuster diabetes drug Avandia.

In Mr. Barlow’s most interesting and challenging pro bono case, he facilitated the return parental visitation rights to the mother of two children after her ex-husband, residing with the children in Malaysia, cut off her access for five years in contravention of U.S. court orders.

Mr. Barlow has an AV–Preeminent peer review rating from Martindale-Hubbell. Currently, he is a Fellowship Member of the Texas Trial Lawyers Association, a member of the American Association for Justice, and a member of Trial Lawyers for Public Justice. He is a past member of the Board of the Texas Trial Lawyers Association.

In law school, Mr. Barlow was the recipient of the George E. Seay Endowed Presidential Scholarship and was a member of the Order of the Coif, a national honorary society for law school students. His invited lectures include: Emerging Mass Torts, TTLA Year-End CLE; How to Win on Cross-examination, TTLA Las Vegas Seminar; Circumstantial Evidence of Scientific Causation, TTLA Mid Year CLE;  Deceptive Trade Practices in Commercial Litigation, TTLA Commercial Litigation Seminar;  Nursing Home Abuse & Neglect Case Evaluation, University of Mississippi Tort Law Seminar;  The Future of Mass Torts, University of Mississippi Tort Law Seminar;  Trying the Low Exposure Asbestos Case, Plaintiff’s Asbestos Litigation Seminar.

Tags: